Aptevo Therapeutics Inc.APVOEarnings & Financial Report
Nasdaq
APVO Q4 2022 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-7.7M
Net Profit
$-4.6M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.96
Aptevo Therapeutics Inc. Q4 2022 Financial Summary
Aptevo Therapeutics Inc. reported revenue of $0 for Q4 2022, with a net profit of $-4.6M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-4.6M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2022 |
Aptevo Therapeutics Inc. Annual Revenue by Year
Aptevo Therapeutics Inc. annual revenue history includes year-by-year totals (for example, 2022 revenue was $3.1M).
| Year | Annual Revenue |
|---|---|
| 2022 | $3.1M |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Revenue | $3.1M | $0 | $0 | $0 |
| YoY Growth | 28.6% | N/A | N/A | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Assets | $45.2M | $38.8M | $31.7M | $34.2M |
| Liabilities | $51.1M | $15.8M | $15.9M | $16.2M |
| Equity | $-5.9M | $23.0M | $15.8M | $18.0M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Operating CF | $-5.1M | $-3.1M | $-6.9M | $-5.9M |